Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to improve cardiovascular and renal outcomes in patients with established cardiovascular disease, chronic kidney disease (CKD), and heart failure (HF) with reduced or preserved ejection fraction. Clinical benefit has been substantia...

Full description

Bibliographic Details
Main Authors: Anjay Rastogi, James L. Januzzi
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Clinical Medicine
Subjects:
cardiac remodeling
cardiovascular outcomes
chronic kidney disease
glomerular pressure
heart failure
mechanism of action
Online Access:https://www.mdpi.com/2077-0383/12/8/2824

Internet

https://www.mdpi.com/2077-0383/12/8/2824

Similar Items